Skip to main content
Account

Peer review reports

From: Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer

Original Submission
22 Apr 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
27 Aug 2015 Editorially accepted
9 Sep 2015 Article published 10.1186/s12885-015-1630-1

Learn about peer review

Back to article page

Navigation